[1]
“DETERMINATION OF TUMOUR MARKER PSA AND RFTs IN PROSTATIC CANCER PATIENTS”, rjnmsr, vol. 4, no. 5, pp. 223–231, May 2026, doi: 10.63075/95pc9k34.